Abstract:Objectives: To investigate the clinical characteristics of bladder urothelial tumors in male patients.Patients and methods: The clinical characteristics of 356 patients with newly diagnosed bladder urothelial tumors from July 2005 to January 2010 were analyzed. Characteristics of different age groups were compared. Furthermore, tumor characteristics were analyzed to define the relationship, if any, with benign prostatic hyperplasia/benign prostatic enlargement.Results: For bladder urothelial tumors, the percentage of carcinoma increased significantly with increasing age (P < 0.001), and differences were found among 3 age groups in the distribution of high grade carcinoma (P = 0.012). Especially in non-muscle-invasive carcinoma, the percentage of high grade carcinoma increased significantly with increasing age (P = 0.006), with significant differences between the <= 50 years group and the 51-69 years group and >= 70 years group (P = 0.031, P = 0.002). Interestingly, compared with non-benign prostatic hyperplasia/benign prostatic enlargement patients, benign prostatic hyperplasia/benign prostatic enlargement patients were more frequently diagnosed with poorly differentiated tumors, and logistic regression confirmed associations between benign prostatic hyperplasia/benign prostatic enlargement and unfavorable carcinoma, controlling for age (P = 0.009).Conclusions: Age is an unfavorable influence on the clinical characteristics of bladder urothelial tumors in men, and it was observed that the percentage of unfavorable tumors increased with age. Interestingly, noticeable changes of tumor differentiation appeared at the age of 50 years, and it was indicated that the natural history of carcinoma appeared to differ according to benign prostatic hyperplasia/benign prostatic enlargement statuses. There was a tendency for the men, who were diagnosed with benign prostatic hyperplasia/benign prostatic enlargement, to present with unfavorable carcinoma. (C) 2012 Elsevier Inc. All rights reserved.

Pathophysiology of benign prostate enlargement and lower urinary tract symptoms: Current concepts

Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review

Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors

Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction

Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction

Natural history and epidemiology of benign prostatic hyperplasia

Lower urinary tract symptoms in elderly men: Considerations for prostate cancer testing

Mitigating Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Ameliorating Sexual Function and Psychological Well-Being in Older Men

The Etiology and Pathogenesis of Benign Prostatic Hyperplasia: The Roles of Sex Hormones and Anatomy

"Current and Emerging Therapies for Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia"

The Human Microbiome and Benign Prostatic Hyperplasia: Current Understandings and Clinical Implications

Benign prostatic hyperplasia – what do we know?

Diet as a risk factor and intervention for lower urinary tract symptoms secondary to benign prostatic hyperplasia

Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS)

Incidence and Prevalence of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in Primary Care—The Triumph Project

Review of the Roles and Interaction of Androgen and Inflammation in Benign Prostatic Hyperplasia

The rising worldwide impact of benign prostatic hyperplasia

Clinical Characteristics Of Bladder Urothelial Tumors In Male Patients-The Influences Of Benign Prostatic Hyperplasia/Benign Prostatic Enlargement

Minimally invasive interventions for lower urinary tract symptoms: What sits between medical therapy and transurethral resection of the prostate

The prevalence and associated factors of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males

Hong Kong Geriatrics Society and Hong Kong Urological Association consensus on personalised management of male lower urinary tract symptoms in the era of multiple co-morbidities and polypharmacy.